Philip Morris
Adhoc Program Advisory Group - Passive Smoking Meeting - National Cancer Institute, Washington, D.C., 810930
Fields
- Author
- Osdene, T.S.
- Author (Organization)
- PM, Philip Morris
- Type
- MEMO, MEMORANDUM
- REPT, REPORT, OTHER
- Area
- LEGAL DEPT/CARLSTADT
- Named Organization
- American Cancer Society
- NCI, Natl Cancer Inst
- Office of Smoking + Health
- PM, Philip Morris
- Ad Hoc Program Advisory Group
- NCI, Natl Cancer Inst
- Named Person
- Adamson
- Auerbach
- Froeb
- Garfinkel
- Hirayama
- Hoffmann
- Luoto, J.
- Owen, T.
- Spears
- Trichopoulos
- White
- Wynder
- A, T.F.
- B, J.C.
- Cullman, H.
- G, C.H.
- P, S.
- Auerbach
- Recipient (Organization)
- PM, Philip Morris
- Document File
- 2024983758/2024983856/Research & Development
- Copied
- Carpenter, R.
- Charles, J.
- Cullman, H.
- Fagain, R.
- Hausermann, M.
- Holtzman, A.
- Mcdowell, W.
- Seligman, R.
- Charles, J.
- Characteristic
- MARG, MARGINALIA
- Litigation
- Stmn/Produced
- Site
- N28
- Request
- Stmn/R1-147
- Master ID
- 2024983800/3806
Related Documents:- 2024983802 Agenda Ad Hoc Program Advisory Group - Passive Smoking National Cancer Institute Division of Cancer Cause and Prevention Special Programs Branch Building 31, Conference Room 8 Bethesda, Md 20205 810930
- 2024983803-3804 List of Participants and Observers Ad Hoc Program Advisory Group - Passive Smoking National Cancer Institute Division of Cancer Cause and Prevention Special Programs Branch Building 31, Conference Room 8 Bethesda, Md 20205 810930
- 2024983805 List of Representatives Ad Hoc Program Advisory Group - Passive Smoking National Cancer Institute Division of Cancer Cause and Prevention Special Programs Branch Building 31, Conference Room 8 Bethesda, Md 20205 810930
- 2024983806 List of Invitees Ad Hoc Program Advisory Group - Passive Smoking National Cancer Institute Division of Cancer Cause and Prevention Special Programs Branch Building 31, Conference Room 8 Bethesda, Md 20205 810930
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- mhh24e00
Document Images
To:
Frmm:
P'FN!I L IP M©RR I S U. S. A. `
RICHMOND, VIRGINIA
,
t ~~~~~~
~~ J
~'..
Memo for ' Record Date:
T. S. Osdene
C'4G
Subject: . Adhoc ProgramiAdvisory Group - Paissive Smoking Meeting -~ ~
National Cancer Institute, Washington, D.C., September 30', j~ rA
-
1981
I attended the meeting on September 30, 1981, in my
capacity as a private citizen. A brief'summary of what
occurred is outlined below.
We met at 9:0i0a.m. and after a brief welcome by Dr.
Adamson, Dr. Wynder opened the meeting. Hie felt,the subject
of sidestream smoke was of' scientific and societal significance.
In addition, he stated that smoking,itself was thie cause of
lung cancer, but whether sidestream smoke was carcinogenic
to man was not clear. He pointed out that to measure thiee
effect of'sidestream smoke on non-smokers would be quite
difficult, and would require large numbers of people for
e~iidemiologicail studies.
Dr. Hoffmann followed with a discussion on sources andi
analyses of polluted indoor environment and pointed to the
increase of nitrosamines in sidestream smoke. He mentioned
that the problem of'sidestreamismoke toxicity could largely
be attributed to the volatile nitrosamines. Since sidestream
is really rather diluted, he did not feel the activity would
be too intense.
This was followed by a review of the Epidemiology of
Passive Smoking in a paper by Dr. Garfinkel of' the American Cancer
Society and he briefly mentioned the White and Froeb paper as
well as the Trichopoulos and Hirayama papers. He said, his
own conclusionis were contrary to the findings of Trichopoulos
and Hirayama. He recalled that in an earlier study which he
conducted withiDr. Auerbach, that Auerbach could predict smokers.
"b7lindi'"' from lung biopsies in which cellular "atypism" was shown. N
He never found atypism, in the non-smoker, and thus it would be ~,
very surprising, if the non-smokers were to be exposed to a
sufficiently large enough dose of smoke which couldicreate this ~
"atypism." Hie felt the problem itself was not of high import- ~,
ance and mentioned that the American Cancer Society is still
debating,the issue. He erso aTl: feels that the bannin of GJ.
smokin g in public places, on on the basis o iscom ort or
irritation, is perfect y acce~pta le. I wou thus say that he
Re..... ... . . . .. '1.
ud, o1d / i9k /
Hugh Cuuiman ,.
----
October 21, 198'1 5 '

Memo for Record' -2- October 21, 1, 1981
should not be considered a great friend of'ttie industry.
Following a brief recess there were additional discussions
by all participants (list of participants is attached) and'the
summary of the meeting was a request that all participants send
one or two specific ideas on what to do in the future to Dr.
Tom Owen. Both Dr. Spears and I, as well as Dr. Garfinkel, felt
that there were matters of greater priority for th~e NCI than
to open up this subjiect. A decision on whether this will lead
to additional work has not yet been made. I might point out
that Dr. Joanne Luoto (Acting Head of the Office of Smoking
and Health and'most likely to be involved in additives nego-
tiations) made several comments on transplaicental carcinogen-
esis. She felt, that on the s:ubjiect of sidestream. smoking, wee
owe the.public an answer. Her priorities, which may change in
a formal submission,were:
1. Examing the existing studies
2. Not to be sanguine about levels ini rooms but
define and evaluate levels of gas phase components
3. Study air flowpatterns of passive smoker
4. Undertake animal testing to see if one can demonstrate
any injury
She then again brought up the subject of transplacental
carcinogenesis which seems to tie heavy on her mind~.
Overall, my feeling is that relatively little will come
of this subJect at the present time due to funding shortages.
However, comments from participants submitted to Dr. Owen, will
be studied for priority evaluation and will th~en be submitted
to the divisional advisory board for possible funding.
/ iw
cc:
Mr.
H.
Cullman
Mr.
Mr.
Dr.
Dr.
Dr.
Mr.
Mr. W.
A.
R.
M.
R.
R.
J. McDowell
Holtzman
Seligman
Hausermann
Fagan
Carpenter
Charles
Enclosure.
